The products are being recalled for having excessively high flow rates that could deliver medications too quickly and cause illness, seizures, heart rhythms and death. Symbios is working to have all affected products returned.
More Articles on Anesthesia:
Can ASCs Profit From Anesthesia? Points on OIG Guidance
ASC Anesthesia Best Practices
4 Ways in Which Anesthesia Departments Can Contribute to an ASC’s Success
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
